1. Home
  2. GETY vs EOLS Comparison

GETY vs EOLS Comparison

Compare GETY & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GETY
  • EOLS
  • Stock Information
  • Founded
  • GETY 1995
  • EOLS 2012
  • Country
  • GETY United States
  • EOLS United States
  • Employees
  • GETY N/A
  • EOLS N/A
  • Industry
  • GETY Industrial Machinery/Components
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • GETY Industrials
  • EOLS Health Care
  • Exchange
  • GETY Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • GETY 723.5M
  • EOLS 589.3M
  • IPO Year
  • GETY N/A
  • EOLS 2018
  • Fundamental
  • Price
  • GETY $1.85
  • EOLS $9.53
  • Analyst Decision
  • GETY Hold
  • EOLS Strong Buy
  • Analyst Count
  • GETY 5
  • EOLS 5
  • Target Price
  • GETY $4.35
  • EOLS $23.75
  • AVG Volume (30 Days)
  • GETY 1.0M
  • EOLS 889.3K
  • Earning Date
  • GETY 08-11-2025
  • EOLS 08-05-2025
  • Dividend Yield
  • GETY N/A
  • EOLS N/A
  • EPS Growth
  • GETY N/A
  • EOLS N/A
  • EPS
  • GETY N/A
  • EOLS N/A
  • Revenue
  • GETY $941,086,000.00
  • EOLS $275,463,000.00
  • Revenue This Year
  • GETY $2.71
  • EOLS $33.42
  • Revenue Next Year
  • GETY $2.74
  • EOLS $33.18
  • P/E Ratio
  • GETY N/A
  • EOLS N/A
  • Revenue Growth
  • GETY 4.20
  • EOLS 25.38
  • 52 Week Low
  • GETY $1.25
  • EOLS $8.67
  • 52 Week High
  • GETY $4.49
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • GETY 52.83
  • EOLS 51.00
  • Support Level
  • GETY $1.63
  • EOLS $9.12
  • Resistance Level
  • GETY $2.06
  • EOLS $10.20
  • Average True Range (ATR)
  • GETY 0.10
  • EOLS 0.40
  • MACD
  • GETY 0.02
  • EOLS 0.05
  • Stochastic Oscillator
  • GETY 50.00
  • EOLS 44.17

About GETY Getty Images Holdings Inc.

Getty Images Holdings Inc. is a visual content creator and marketplace that offers a full range of content solutions. Through its Getty Images, Stock, and Unsplash brands, websites, and APIs, it serves customers around the world by allowing them to discover, purchase, and share visual content from photographers, illustrators, image partners, and videographers. The company generates a majority of its revenue through subscriptions, offering various subscription products on the Getty Images, iStock, and Unsplash websites. It operates and manages one operating segment, which is the business of developing and commercializing visual content. Geographically, the company generates maximum revenue from the Americas, followed by Europe, the Middle East and Africa, and the Asia-Pacific region.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: